Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Equity Income Wisdomtree | DHS | Dec 31, 2024 | 93.36 | +0.54 |
Equity Lifestyle Properties | ELS | Dec 31, 2024 | 66.60 | +0.82 |
Equity Residential | EQR | Dec 31, 2024 | 71.76 | +0.84 |
Equus Total Return | EQS | Dec 31, 2024 | 1.10 | +1.85 |
EQV Ventures Acquisition | EQV | Dec 31, 2024 | 9.98 | 0.00 |
Erasca | ERAS | Dec 31, 2024 | 2.51 | -1.57 |
Erayak Power Solution Group A | RAYA | Dec 31, 2024 | 1.36 | -2.86 |
Ericsson B ADR | ERIC | Dec 31, 2024 | 8.06 | -0.25 |
Erie Indemnity A | ERIE | Dec 31, 2024 | 412.23 | +0.21 |
Ermenegildo Zegna N.V. | ZGN | Dec 31, 2024 | 8.26 | +0.12 |
Ero Copper | ERO | Dec 31, 2024 | 13.48 | +1.20 |
ESAB | ESAB | Dec 31, 2024 | 119.94 | -0.21 |
Escalade | ESCA | Dec 31, 2024 | 14.28 | +0.71 |
Esco Technologies | ESE | Dec 31, 2024 | 133.21 | -0.06 |
ESGL | ESGL | Dec 31, 2024 | 1.33 | -0.05 |
ESH Acquisition | ESHA | Dec 31, 2024 | 10.77 | 0.00 |
Eshallgo | EHGO | Dec 31, 2024 | 3.84 | +5.49 |
Esperion Therapeutics | ESPR | Dec 31, 2024 | 2.20 | +2.33 |
Espey Mfg & Electronics | ESP | Dec 31, 2024 | 30.15 | -0.33 |
Esquire Financial | ESQ | Dec 31, 2024 | 79.50 | -0.55 |
ESS Tech | GWH | Dec 31, 2024 | 5.88 | -4.23 |
ESSA Bancorp | ESSA | Dec 31, 2024 | 19.50 | +1.14 |
ESSA Pharma | EPIX | Dec 31, 2024 | 1.79 | -0.56 |
Essent Group | ESNT | Dec 31, 2024 | 54.44 | +0.57 |
Essential Properties Realty Trust | EPRT | Dec 31, 2024 | 31.28 | +0.22 |
Essential Utilities | WTRG | Dec 31, 2024 | 36.32 | +0.28 |
Essex Property Trust | ESS | Dec 31, 2024 | 285.44 | +0.93 |
Establishment Labs | ESTA | Dec 31, 2024 | 46.07 | +1.54 |
Estee Lauder Companies | EL | Dec 31, 2024 | 74.98 | +1.06 |
Estrella Immunopharma | ESLA | Dec 31, 2024 | 1.20 | -3.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.